Driehaus Capital Management LLC Bio Techne Corp Transaction History

Driehaus Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$322.67 - $449.65 $223,610 - $311,607	693 Added 2.59%	27,408 $9.5 Million
Q1 2022 May 16, 2022	SELL	$353.85 - $487.79 $3.51 Million - $4.84 Million	-9,930 Reduced 27.1%	26,715 $11.6 Million
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $15,509 - $17,852	34 Added 0.09%	36,645 $19 Million
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $14.6 Million - $17.7 Million	32,915 Added 890.56%	36,611 $17.7 Million
Q2 2021 Aug 16, 2021	BUY	$387.35 - $450.26 $543,064 - $631,264	1,402 Added 61.12%	3,696 $1.66 Million
Q1 2021 May 17, 2021	BUY	$314.62 - $411.0 $151,646 - $198,102	482 Added 26.6%	2,294 $876,000
Q4 2020 Feb 16, 2021	BUY	$246.9 - $321.87 $447,382 - $583,228	1,812 New	1,812 $575,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.94B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.